RecruitingNot ApplicableNCT04880226

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation

Evaluation of Non Significant Risk Operation Magnetic Resonance Imaging for MR Guided Ablation Using the Philips MRI


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Aug 30, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Male or female.
  • Age ≥ 18 years.
  • Healthy volunteers or patients already scheduled for a MR-guided procedure.

Exclusion Criteria2

  • Individuals 18 years of age.
  • Pregnant women.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMagnetic Resonance Imaging (MRI)

Ongoing evaluations of magnetic resonance imaging (MRI) using the Philips Ingenua 1.5T scanner associated with MRI-guided procedures (e.g. ablations or biopsies) are essential to continued procedure improvement within the newly-built hybrid procedure suite.


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04880226


Related Trials